Raising the bar for the adjuvant treatment of pancreatic cancer.
Division of Hematology/Oncology Gastrointestinal Oncology Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco CA 94143, USA. Electronic address: Andrew.Ko@ucsf.edu.
Andrew H
AH
Ko
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D044584:Carcinoma, Ductal / Q000628:therapy*; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D010094:Oxonic Acid / Q000008:administration & dosage*; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000628:therapy*; D005641:Tegafur / Q000008:administration & dosage*
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D005641:Tegafur; D010094:Oxonic Acid